Supplementary Figure S4 shows the microbiota composition in the pools from CAC and control mice used for FMT and the changes in relative abundance of unique bacteria following disease progression.
No takes yet. Share an insight, caveat, or question.
Ashkenazi‐Preiser et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: